A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer

Lung Cancer

Volumn 73, Issue 2, 2011, Pages 133-137

  Shen, Min ^a   Cawthon, Richard ^b   Rothman, Nathaniel ^a   Weinstein, Stephanie J ^a   Virtamo, Jarmo ^c   Hosgood, H Dean ^a   Hu, Wei ^a   Lim, Unhee ^d   Albanes, Demetrius ^a   Lan, Qing ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Cohort study; Lung cancer; Telomere length

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; INCIDENCE; LEUKOCYTE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MONOCHROME MULTIPLEX QUANTITATIVE POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TELOMERE;

AGED; CASE-CONTROL STUDIES; CHROMOSOMAL INSTABILITY; COHORT STUDIES; GENETIC MARKERS; HUMANS; LEUKOCYTES; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STATISTICS, NONPARAMETRIC; TELOMERE;

EID: 79960034290     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.11.009     Document Type: Article

References (25)

1. Cheung A.L., Deng W. Telomere dysfunction, genome instability and cancer. Front Biosci 2008, 13:2075-2090.
2. Raynaud C.M., Sabatier L., Philipot O., Olaussen K.A., Soria J.C. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Crit Rev Oncol Hematol 2008, 66:99-117.
3. Londono-Vallejo J.A. Telomere instability and cancer. Biochimie 2008, 90:73-82.
4. Djojosubroto M.W., Choi Y.S., Lee H.W., Rudolph K.L. Telomeres and telomerase in aging, regeneration and cancer. Mol Cells 2003, 15:164-175.
5. Broberg K., Bjork J., Paulsson K., Hoglund M., Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005, 26:1263-1271.
6. Jang J.S., Choi Y.Y., Lee W.K., Choi J.E., Cha S.I., Kim Y.J., et al. Telomere length and the risk of lung cancer. Cancer Sci 2008, 99:1385-1389.
7. McGrath M., Wong J.Y., Michaud D., Hunter D.J., De V.I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007, 16:815-819.
8. Risques R.A., Vaughan T.L., Li X., Odze R.D., Blount P.L., Ayub K., et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007, 16:2649-2655.
9. Shen J., Terry M.B., Gurvich I., Liao Y., Senie R.T., Santella R.M. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007, 67:5538-5544.
10. Widmann T.A., Herrmann M., Taha N., Konig J., Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol 2007, 35:939-946.
11. Wu X., Amos C.I., Zhu Y., Zhao H., Grossman B.H., Shay J.W., et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003, 95:1211-1218.
12. Han J., Qureshi A.A., Prescott J., Guo Q., Ye L., Hunter D.J., et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 2009, 129(2):415-421.
13. Svenson U., Nordfjall K., Stegmayr B., Manjer J., Nilsson P., Tavelin B., et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 2008, 68:3618-3623.
14. The ATBC Cancer Prevention Study Group The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 1994, 4:1-10.
15. Korhonen P., Malila N., Pukkala E., Teppo L., Albanes D., Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002, 41:381-388.
16. Cawthon R.M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009, 37:e21.
17. Friedrich U., Griese E.U., Schwab M., Fritz P., Thon K.P., Klotz U. Telomere length in different tissues of elderly patients. Mech Ageing Dev 2000, 119:89-99.
18. Mooi W.J., Peeper D.S. Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 2006, 355:1037-1046.
19. Pooley K.A., Sandhu M.S., Tyrer J., Shah M., Driver K.E., Luben R.N., Bingham S.A., Ponder B.A., Pharoah P.D., Khaw K.T., Easton D.F., Dunning A.M. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 2010, 70:3170-3176.
20. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA. The association of telomere length and cancer: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 2011 Apr 5.[Epub].
21. Lan Q., Cawthon R., Shen M., Weinstein S.J., Virtamo J., Lim U., Hosgood H.D., Albanes D., Rothman N. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 2009, 15:7429-7433.
22. Lee J.J., Nam C.E., Cho S.H., Park K.S., Chung I.J., Kim H.J. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol 2003, 82:492-495.
23. Yoon S.Y., Sung H.J., Park K.H., Choi I.K., Kim S.J., Oh S.C., et al. Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity. Acta Haematol 2007, 118:30-37.
24. Hoffmann J., Erben Y., Zeiher A.M., Dimmeler S., Spyridopoulos I Telomere length-heterogeneity among myeloid cells is a predictor for chronological ageing. Exp Gerontol 2009, 44:363-366.
25. Spyridopoulos I., Erben Y., Brummendorf T.H., Haendeler J., Dietz K., Seeger F., et al. Telomere gap between granulocytes and lymphocytes is a determinant for hematopoetic progenitor cell impairment in patients with previous myocardial infarction. Arterioscler Thromb Vasc Biol 2008, 28:968-974.